Interaction between gastric and upper small intestinal hormones in the regulation of hunger and satiety: Ghrelin and cholecystokinin take the central stage

Current Protein and Peptide Science

Volumn 12, Issue 4, 2011, Pages 293-304

  Stengel, Andreas ^a   Taché, Yvette ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Brain gut; Duodenum; Food intake; Gut peptides; Stomach; Vagus

Indexed keywords

AMYLIN; ANANDAMIDE; BOMBESIN; CANNABINOID 1 RECEPTOR; CHOLECYSTOKININ; GHRELIN; GLUCAGON LIKE PEPTIDE 1; HORMONE; INSULIN; LEPTIN; MELANIN CONCENTRATING HORMONE RECEPTOR 1; NESFATIN 1; NUCLEOBINDIN2; OBESTATIN; SOMATOSTATIN; UNCLASSIFIED DRUG; UROCORTIN II;

ALTERNATIVE RNA SPLICING; ARTICLE; BLOOD SAMPLING; DUODENUM; FOOD INTAKE; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RECEPTOR INTERACTION; HORMONE RELEASE; HUMAN; HUNGER; NONHUMAN; PROTEIN PROCESSING; SATIETY;

ANIMALS; CHOLECYSTOKININ; EATING; GASTROINTESTINAL HORMONES; GHRELIN; HUMANS; HUNGER; SATIETY RESPONSE;

EID: 79959982884     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/138920311795906673     Document Type: Article

References (171)

1. Moran, T.H.; Dailey, M.J. Minireview: Gut peptides: targets for antiobesity drug development? Endocrinology, 2009, 150(6), 2526-2530.
2. Karra, E.; Batterham, R.L. The role of gut hormones in the regulation of body weight and energy homeostasis. Mol. Cell. Endocrinol., 2010, 316(2), 120-128.
3. Kojima, M.; Hosoda, H.; Date, Y.; Nakazato, M.; Matsuo, H.; Kangawa, K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 1999, 402(6762), 656-560.
4. Ariyasu, H.; Takaya, K.; Tagami, T.; Ogawa, Y.; Hosoda, K.; Akamizu, T.; Suda, M.; Koh, T.; Natsui, K.; Toyooka, S.; Shirakami, G.; Usui, T.; Shimatsu, A.; Doi, K.; Hosoda, H.; Kojima, M.; Kangawa, K.; Nakao, K. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J. Clin. Endocrinol. Metab., 2001, 86(10), 4753-4658.
5. Jeon, T.Y.; Lee, S.; Kim, H.H.; Kim, Y.J.; Son, H.C.; Kim, D.H.; Sim, M.S. Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J. Clin. Endocrinol. Metab., 2004, 89(11), 5392-5396.
6. Date, Y.; Kojima, M.; Hosoda, H.; Sawaguchi, A.; Mondal, M.S.; Suganuma, T.; Matsukura, S.; Kangawa, K.; Nakazato, M. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology, 2000, 141(11), 4255-4261.
7. Date, Y.; Nakazato, M.; Hashiguchi, S.; Dezaki, K.; Mondal, M.S.; Hosoda, H.; Kojima, M.; Kangawa, K.; Arima, T.; Matsuo, H.; Yada, T.; Matsukura, S. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes, 2002, 51(1), 124-129.
8. Gnanapavan, S.; Kola, B.; Bustin, S.A.; Morris, D.G.; McGee, P.; Fairclough, P.; Bhattacharya, S.; Carpenter, R.; Grossman, A.B.; Korbonits, M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab., 2002, 87(6), 2988.
9. Barreiro, M.L.; Gaytan, F.; Caminos, J.E.; Pinilla, L.; Casanueva, F.F.; Aguilar, E.; Dieguez, C.; Tena-Sempere, M. Cellular location and hormonal regulation of ghrelin expression in rat testis. Biol. Reprod., 2002, 67(6), 1768-1776.
10. Bednarek, M.A.; Feighner, S.D.; Pong, S.S.; McKee, K.K.; Hreniuk, D.L.; Silva, M.V.; Warren, V.A.; Howard, A.D.; Van Der Ploeg, L.H.; Heck, J.V. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J. Med. Chem., 2000, 43(23), 4370-4376.
11. Kojima, M.; Kangawa, K. Ghrelin: structure and function. Physiol. Rev., 2005, 85(2), 495-522.
12. Hiejima, H.; Nishi, Y.; Hosoda, H.; Yoh, J.; Mifune, H.; Satou, M.; Sugimoto, H.; Chiba, S.; Kawahara, Y.; Tanaka, E.; Yoshimatsu, H.; Uchimura, N.; Kangawa, K.; Kojima, M. Regional distribution and the dynamics of n-decanoyl ghrelin, another acyl-form of ghrelin, upon fasting in rodents. Regul. Pept., 2009, 156(1-3), 47-56.
13. Yang, J.; Brown, M.S.; Liang, G.; Grishin, N.V.; Goldstein, J.L. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell, 2008, 132(3), 387-396.
14. Gutierrez, J.A.; Solenberg, P.J.; Perkins, D.R.; Willency, J.A.; Knierman, M.D.; Jin, Z.; Witcher, D.R.; Luo, S.; Onyia, J.E.; Hale, J.E. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc. Natl. Acad. Sci. U S A, 2008, 105(17), 6320-5325.
15. Sakata, I.; Yang, J.; Lee, C.E.; Osborne-Lawrence, S.; Rovinsky, S.A.; Elmquist, J.K.; Zigman, J.M. Colocalization of ghrelin Oacyltransferase and ghrelin in gastric mucosal cells. Am. J. Physiol. Endocrinol. Metab., 2009, 297(1), E134-E141.
16. Stengel, A.; Goebel, M.; Wang, L.; Taché, Y.; Sachs, G.; Lambrecht, N.W. Differential distribution of ghrelin-O-acyltransferase (GOAT) immunoreactive cells in the mouse and rat gastric oxyntic mucosa. Biochem. Biophys. Res. Commun., 2010, 392(1), 67-71.
17. Cummings, D.E.; Purnell, J.Q.; Frayo, R.S.; Schmidova, K.; Wisse, B.E.; Weigle, D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes, 2001, 50(8), 1714-1719.
18. Hass, N.; Schwarzenbacher, K.; Breer, H. T1R3 is expressed in brush cells and ghrelin-producing cells of murine stomach. Cell Tissue Res., 2010, 339(3), 493-504.
19. Foster-Schubert, K.E.; Overduin, J.; Prudom, C.E.; Liu, J.; Callahan, H.S.; Gaylinn, B.D.; Thorner, M.O.; Cummings, D.E. Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. J. Clin. Endocrinol. Metab., 2008, 93(5), 1971-1979.
20. Tschop, M.; Smiley, D.L.; Heiman, M.L. Ghrelin induces adiposity in rodents. Nature, 2000, 407(6806), 908-913.
21. Cummings, D.E.; Weigle, D.S.; Frayo, R.S.; Breen, P.A.; Ma, M.K.; Dellinger, E.P.; Purnell, J.Q. Plasma ghrelin levels after dietinduced weight loss or gastric bypass surgery. N. Engl. J. Med., 2002, 346(21), 1623-1630.
22. Cummings, D.E.; Clement, K.; Purnell, J.Q.; Vaisse, C.; Foster, K.E.; Frayo, R.S.; Schwartz, M.W.; Basdevant, A.; Weigle, D.S. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat. Med., 2002, 8(7), 643-644.
23. Howard, A.D.; Feighner, S.D.; Cully, D.F.; Arena, J.P.; Liberator, P.A.; Rosenblum, C.I.; Hamelin, M.; Hreniuk, D.L.; Palyha, O.C.; Anderson, J.; Paress, P.S.; Diaz, C.; Chou, M.; Liu, K.K.; McKee, K.K.; Pong, S.S.; Chaung, L.Y.; Elbrecht, A.; Dashkevicz, M.; Heavens, R.; Rigby, M.; Sirinathsinghji, D.J.; Dean, D.C.; Melillo, D.G.; Patchett, A.A.; Nargund, R.; Griffin, P.R.; DeMartino, J.A.; Gupta, S.K.; Schaeffer, J.M.; Smith, R.G.; Van der Ploeg, L.H. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science, 1996, 273(5277), 974-977.
24. Guan, X.M.; Yu, H.; Palyha, O.C.; McKee, K.K.; Feighner, S.D.; Sirinathsinghji, D.J.; Smith, R.G.; Van der Ploeg, L.H.; Howard, A.D. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res. Mol. Brain Res., 1997, 48(1), 23-29.
25. Nakazato, M.; Murakami, N.; Date, Y.; Kojima, M.; Matsuo, H.; Kangawa, K.; Matsukura, S. A role for ghrelin in the central regulation of feeding. Nature, 2001, 409(6817), 194-198.
26. Hattori, N.; Saito, T.; Yagyu, T.; Jiang, B.H.; Kitagawa, K.; Inagaki, C. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J. Clin. Endocrinol. Metab., 2001, 86(9), 4284-4291.
27. Schellekens, H.; Dinan, T.G.; Cryan, J.F. Lean Mean Fat Reducing Ghrelin Machine: Hypothalamic Ghrelin and Ghrelin Receptors as Therapeutic Targets in Obesity. Neuropharmacology, 2010, 58(1), 2-16.
28. Zigman, J.M.; Jones, J.E.; Lee, C.E.; Saper, C.B.; Elmquist, J.K. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J. Comp. Neurol., 2006, 494(3), 528-548.
29. Shuto, Y.; Shibasaki, T.; Wada, K.; Parhar, I.; Kamegai, J.; Sugihara, H.; Oikawa, S.; Wakabayashi, I. Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHSR): evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of rats. Life Sci., 2001, 68(9), 991-996.
30. Mondal, M.S.; Date, Y.; Yamaguchi, H.; Toshinai, K.; Tsuruta, T.; Kangawa, K.; Nakazato, M. Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus. Regul. Pept., 2005, 126(1-2), 55-59.
31. Holst, B.; Schwartz, T.W. Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation. Trends Pharmacol. Sci., 2004, 25(3), 113-117.
32. Schellekens, H.; Dinan, T.G.; Cryan, J.F. Lean Mean Fat Reducing Ghrelin Machine: Hypothalamic Ghrelin and Ghrelin Receptors as Therapeutic Targets in Obesity. Neuropharmacology, 2010, 58(1), 2-16.
33. Wren, A.M.; Small, C.J.; Ward, H.L.; Murphy, K.G.; Dakin, C.L.; Taheri, S.; Kennedy, A.R.; Roberts, G.H.; Morgan, D.G.; Ghatei, M.A.; Bloom, S.R. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology, 2000, 141(11), 4325-4328.
34. Druce, M.R.; Wren, A.M.; Park, A.J.; Milton, J.E.; Patterson, M.; Frost, G.; Ghatei, M.A.; Small, C.; Bloom, S.R. Ghrelin increases food intake in obese as well as lean subjects. Int. J. Obes. (Lond), 2005, 29(9), 1130-1136.
35. Sun, Y.; Wang, P.; Zheng, H.; Smith, R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. USA, 2004, 101(13), 4679-84.
36. Zigman, J.M.; Nakano, Y.; Coppari, R.; Balthasar, N.; Marcus, J.N.; Lee, C.E.; Jones, J.E.; Deysher, A.E.; Waxman, A.R.; White, R.D.; Williams, T.D.; Lachey, J.L.; Seeley, R.J.; Lowell, B.B.; Elmquist, J.K. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J. Clin. Invest., 2005, 115(12), 3564-3572.
37. Salome, N.; Haage, D.; Perrissoud, D.; Moulin, A.; Demange, L.; Egecioglu, E.; Fehrentz, J.A.; Martinez, J.; Dickson, S.L. Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1A) antagonists in rats. Eur. J. Pharmacol., 2009, 612(1-3), 167-173.
38. Banks, W.A.; Tschop, M.; Robinson, S.M.; Heiman, M.L. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J. Pharmacol. Exp. Ther., 2002, 302(2), 822-827.
39. Pan, W.; Tu, H.; Kastin, A.J. Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides, 2006, 27(4), 911-916.
40. Date, Y.; Murakami, N.; Toshinai, K.; Matsukura, S.; Niijima, A.; Matsuo, H.; Kangawa, K.; Nakazato, M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology, 2002, 123(4), 1120-1128.
41. Sakata, I.; Yamazaki, M.; Inoue, K.; Hayashi, Y.; Kangawa, K.; Sakai, T. Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci. Lett., 2003, 342(3), 183-186.
42. Takayama, K.; Johno, Y.; Hayashi, K.; Yakabi, K.; Tanaka, T.; Ro, S. Expression of c-Fos protein in the brain after intravenous injection of ghrelin in rats. Neurosci. Lett., 2007, 417(3), 292-296.
43. Faulconbridge, L.F.; Cummings, D.E.; Kaplan, J.M.; Grill, H.J. Hyperphagic effects of brainstem ghrelin administration. Diabetes, 2003, 52(9), 2260-2265.
44. Date, Y.; Shimbara, T.; Koda, S.; Toshinai, K.; Ida, T.; Murakami, N.; Miyazato, M.; Kokame, K.; Ishizuka, Y.; Ishida, Y.; Kageyama, H.; Shioda, S.; Kangawa, K.; Nakazato, M. Peripheral ghrelin transmits orexigenic signals through the noradrenergic pathway from the hindbrain to the hypothalamus. Cell. Metab., 2006, 4(4), 323-331.
45. Arnold, M.; Mura, A.; Langhans, W.; Geary, N. Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J. Neurosci., 2006, 26(43), 11052-11060.
46. Lu, S.; Guan, J.L.; Wang, Q.P.; Uehara, K.; Yamada, S.; Goto, N.; Date, Y.; Nakazato, M.; Kojima, M.; Kangawa, K.; Shioda, S. Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci. Lett., 2002, 321(3), 157-160.
47. Schwartz, M.W.; Woods, S.C.; Porte, D., Jr.; Seeley, R.J.; Baskin, D.G. Central nervous system control of food intake. Nature, 2000, 404(6778), 661-671.
48. Cowley, M.A.; Smith, R.G.; Diano, S.; Tschop, M.; Pronchuk, N.; Grove, K.L.; Strasburger, C.J.; Bidlingmaier, M.; Esterman, M.; Heiman, M.L.; Garcia-Segura, L.M.; Nillni, E.A.; Mendez, P.; Low, M.J.; Sotonyi, P.; Friedman, J.M.; Liu, H.; Pinto, S.; Colmers, W.F.; Cone, R.D.; Horvath, T.L. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron, 2003, 37(4), 649-661.
49. Guan, J.L.; Wang, Q.P.; Kageyama, H.; Takenoya, F.; Kita, T.; Matsuoka, T.; Funahashi, H.; Shioda, S. Synaptic interactions between ghrelin- and neuropeptide Y-containing neurons in the rat arcuate nucleus. Peptides, 2003, 24(12), 1921-1928.
50. Abizaid, A.; Horvath, T.L. Brain circuits regulating energy homeostasis. Regul. Pept., 2008, 149(1-3), 3-10.
51. Kamegai, J.; Tamura, H.; Shimizu, T.; Ishii, S.; Sugihara, H.; Wakabayashi, I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes, 2001, 50(11), 2438-2443.
52. Wang, L.; Saint-Pierre, D.H.; Taché, Y. Peripheral ghrelin selectively increases Fos expression in neuropeptide Y - synthesizing neurons in mouse hypothalamic arcuate nucleusNeurosci. Lett., 2002, 325(1), 47-51.
53. Chen, H.Y.; Trumbauer, M.E.; Chen, A.S.; Weingarth, D.T.; Adams, J.R.; Frazier, E.G.; Shen, Z.; Marsh, D.J.; Feighner, S.D.; Guan, X.M.; Ye, Z.; Nargund, R.P.; Smith, R.G.; Van der Ploeg, L.H.; Howard, A.D.; MacNeil, D.J.; Qian, S. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology, 2004, 145(6), 2607-2612.
54. Pfluger, P.T.; Kirchner, H.; Gunnel, S.; Schrott, B.; Perez-Tilve, D.; Fu, S.; Benoit, S.C.; Horvath, T.; Joost, H.G.; Wortley, K.E.; Sleeman, M.W.; Tschop, M.H. Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure. Am. J. Physiol. Gastrointest. Liver Physiol., 2008, 294(3), G610-G618
55. Wortley, K.E.; Anderson, K.D.; Garcia, K.; Murray, J.D.; Malinova, L.; Liu, R.; Moncrieffe, M.; Thabet, K.; Cox, H.J.; Yancopoulos, G.D.; Wiegand, S.J.; Sleeman, M.W. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc. Natl. Acad. Sci. USA, 2004, 101(21), 8227-32.
56. Raff, H. Total and active ghrelin in developing rats during hypoxia. Endocrine, 2003, 21(2), 159-561.
57. Hosoda, H.; Kojima, M.; Matsuo, H.; Kangawa, K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem. Biophys. Res. Commun., 2000, 279(3), 909-913.
58. Stengel, A., Keire, D., Goebel, M., Evilevitch, L., Wiggins, B., Taché, Y., Reeve, J.R.Jr. The RAPID method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides. Endocrinology, 2009, 150(11), 5113-5118.
59. Gauna, C.; Delhanty, P.J.; van Aken, M.O.; Janssen, J.A.; Themmen, A.P.; Hofland, L.J.; Culler, M.; Broglio, F.; Ghigo, E.; van der Lely, A.J. Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor. Mol. Cell. Endocrinol., 2006, 251(1-2), 103-111.
60. Gauna, C.; Delhanty, P.J.; Hofland, L.J.; Janssen, J.A.; Broglio, F.; Ross, R.J.; Ghigo, E.; van der Lely, A.J. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J. Clin. Endocrinol. Metab., 2005, 90(2), 1055-1060.
61. Baldanzi, G.; Filigheddu, N.; Cutrupi, S.; Catapano, F.; Bonissoni, S.; Fubini, A.; Malan, D.; Baj, G.; Granata, R.; Broglio, F.; Papotti, M.; Surico, N.; Bussolino, F.; Isgaard, J.; Deghenghi, R.; Sinigaglia, F.; Prat, M.; Muccioli, G.; Ghigo, E.; Graziani, A. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell Biol., 2002, 159(6), 1029-1037.
62. Muccioli, G.; Pons, N.; Ghe, C.; Catapano, F.; Granata, R.; Ghigo, E. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. Eur. J. Pharmacol., 2004, 498(1-3), 27-35.
63. Bulgarelli, I.; Tamiazzo, L.; Bresciani, E.; Rapetti, D.; Caporali, S.; Lattuada, D.; Locatelli, V.; Torsello, A. Desacyl-ghrelin and synthetic GH-secretagogues modulate the production of inflammatory cytokines in mouse microglia cells stimulated by beta-amyloid fibrils. J. Neurosci. Res., 2009, 87(12), 2718-2727.
64. Filigheddu, N.; Gnocchi, V.F.; Coscia, M.; Cappelli, M.; Porporato, P.E.; Taulli, R.; Traini, S.; Baldanzi, G.; Chianale, F.; Cutrupi, S.; Arnoletti, E.; Ghe, C.; Fubini, A.; Surico, N.; Sinigaglia, F.; Ponzetto, C.; Muccioli, G.; Crepaldi, T.; Graziani, A. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol. Biol. Cell, 2007, 18(3), 986-994.
65. Cassoni, P.; Papotti, M.; Ghe, C.; Catapano, F.; Sapino, A.; Graziani, A.; Deghenghi, R.; Reissmann, T.; Ghigo, E.; Muccioli, G. Identification, characterization, and biological activity of specifreceptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J. Clin. Endocrinol. Metab., 2001, 86(4), 1738-1745.
66. Chen, C.Y.; Inui, A.; Asakawa, A.; Fujino, K.; Kato, I.; Chen, C.C.; Ueno, N.; Fujimiya, M. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology, 2005, 129(1), 8-25.
67. Asakawa, A.; Inui, A.; Fujimiya, M.; Sakamaki, R.; Shinfuku, N.; Ueta, Y.; Meguid, M.M.; Kasuga, M. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut, 2005, 54(1), 18-24.
68. Toshinai, K.; Yamaguchi, H.; Sun, Y.; Smith, R.G.; Yamanaka, A.; Sakurai, T.; Date, Y.; Mondal, M.S.; Shimbara, T.; Kawagoe, T.; Murakami, N.; Miyazato, M.; Kangawa, K.; Nakazato, M. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology, 2006, 147(5), 2306-2314.
69. Neary, N.M.; Druce, M.R.; Small, C.J.; Bloom, S.R. Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. Gut, 2006, 55(1), 135.
70. Inhoff, T.; Mönnikes, H.; Noetzel, S.; Stengel, A.; Goebel, M.; Dinh, Q.T.; Riedl, A.; Bannert, N.; Wisser, A.S.; Wiedenmann, B.; Klapp, B.F.; Taché, Y.; Kobelt, P. Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats. Peptides, 2008, 29(12), 2159-2168.
71. Kumar, R.; Salehi, A.; Rehfeld, J.F.; Hoglund, P.; Lindstrom, E.; Hakanson, R. Proghrelin peptides: Desacyl ghrelin is a powerful inhibitor of acylated ghrelin, likely to impair physiological effects of acyl ghrelin but not of obestatin A study of pancreatic polypeptide secretion from mouse islets. Regul. Pept., 2010, 164(2-3), 65-70.
72. Zhang, J.V.; Ren, P.G.; Avsian-Kretchmer, O.; Luo, C.W.; Rauch, R.; Klein, C.; Hsueh, A.J. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science, 2005, 310(5750), 996-999.
73. Stengel, A.; Goebel, M.; Yakubov, I.; Wang, L.; Witcher, D.; Coskun, T.; Taché, Y.; Sachs, G.; Lambrecht, N.W. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology, 2009, 150(1), 232-238.
74. Gronberg, M.; Tsolakis, A.V.; Magnusson, L.; Janson, E.T.; Saras, J. Distribution of Obestatin and Ghrelin in Human Tissues: Immunoreactive Cells in the Gastrointestinal Tract, Pancreas, and Mammary Glands. J. Histochem. Cytochem., 2008, 56(9), 793-801.
75. Tsolakis, A.V.; Grimelius, L.; Stridsberg, M.; Falkmer, S.E.; Waldum, H.L.; Saras, J.; Janson, E.T. Obestatin/ghrelin cells in normal mucosa and endocrine tumours of the stomach. Eur. J. Endocrinol., 2009, 160(6), 941-949.
76. Zhao, C.M.; Furnes, M.W.; Stenstrom, B.; Kulseng, B.; Chen, D. Characterization of obestatin- and ghrelin-producing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electron-microscopic study. Cell Tissue Res., 2008, 331(3), 575-587.
77. Lauwers, E.; Landuyt, B.; Arckens, L.; Schoofs, L.; Luyten, W. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem. Biophys. Res. Commun., 2006, 351(1), 21-25.
78. Tremblay, F.; Perreault, M.; Klaman, L.D.; Tobin, J.F.; Smith, E.; Gimeno, R.E. Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology, 2007, 148(2), 501-506.
79. Holst, B.; Egerod, K.L.; Schild, E.; Vickers, S.P.; Cheetham, S.; Gerlach, L.O.; Storjohann, L.; Stidsen, C.E.; Jones, R.; Beck-Sickinger, A.G.; Schwartz, T.W. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology, 2007, 148(1), 13-20.
80. Chartrel, N.; Alvear-Perez, R.; Leprince, J.; Iturrioz, X.; Reaux-Le Goazigo, A.; Audinot, V.; Chomarat, P.; Coge, F.; Nosjean, O.; Rodriguez, M.; Galizzi, J.P.; Boutin, J.A.; Vaudry, H.; Llorens-Cortes, C. Comment on Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science, 2007, 315(5813), 766; author reply 766.
81. Zhang, J.V., Klein, C., Ren, P-G., Kass, S., Donck, L.V., Moechars, D., Hsueh, A.J.W. Response to Comment on Obestatin, a Peptide Encoded by the Ghrelin Gene, Opposes Ghrelin's Effects on Food Intake. Science, 2007, 315, 766d.
82. Beck, B.; Bossenmeyer-Pourie, C.; Pourie, G. Association of neuropeptide W, but not obestatin, with energy intake and endocrine status in Zucker rats. A new player in long-term stress-feeding interactions. Appetite, 2010, 55(2), 319-24.
83. Bang, A.S.; Soule, S.G.; Yandle, T.G.; Richards, A.M.; Pemberton, C.J. Characterisation of proghrelin peptides in mammalian tissue and plasma. J. Endocrinol., 2007, 192(2), 313-323.
84. Mondal, M.; Toshinai, K.; Ueno, H.; Koshinaka, K.; Nakazato, M. Characterization of obestatin in rat and human stomach and plasma, and its lack of acute effect on feeding behavior in rodents. J. Endocrinol., 2008, 198(2), 339-346.
85. Seoane, L.M.; Al-Massadi, O.; Pazos, Y.; Pagotto, U.; Casanueva, F.F. Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J. Endocrinol. Invest., 2006, 29(8), RC13-RC15.
86. Moechars, D.; Depoortere, I.; Moreaux, B.; de Smet, B.; Goris, I.; Hoskens, L.; Daneels, G.; Kass, S.; Ver Donck, L.; Peeters, T.; Coulie, B. Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse. Gastroenterology, 2006, 131(4), 1131-1141.
87. Gourcerol, G.; Million, M.; Adelson, D.W.; Wang, Y.; Wang, L.; Rivier, J.; St-Pierre, D.H.; Taché, Y. Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents. Peptides, 2006, 27(11), 2811-2819.
88. Samson, W.K.; White, M.M.; Price, C.; Ferguson, A.V. Obestatin acts in brain to inhibit thirst. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2007, 292(1), R637-R643.
89. Lagaud, G.J.; Young, A.; Acena, A.; Morton, M.F.; Barrett, T.D.; Shankley, N.P. Obestatin reduces food intake and suppresses body weight gain in rodents. Biochem. Biophys. Res. Commun., 2007, 357(1), 264-269.
90. Yamamoto, D.; Ikeshita, N.; Daito, R.; Herningtyas, E.H.; Toda, K.; Takahashi, K.; Iida, K.; Takahashi, Y.; Kaji, H.; Chihara, K.; Okimura, Y. Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats. Regul. Pept., 2007, 138(2-3), 141-144.
91. Zizzari, P.; Longchamps, R.; Epelbaum, J.; Bluet-Pajot, M.T. Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology, 2007, 148(4), 1648-1653.
92. Nogueiras, R.; Pfluger, P.; Tovar, S.; Arnold, M.; Mitchell, S.; Morris, A.; Perez-Tilve, D.; Vazquez, M.J.; Wiedmer, P.; Castaneda, T.R.; DiMarchi, R.; Tschop, M.; Schurmann, A.; Joost, H.G.; Williams, L.M.; Langhans, W.; Dieguez, C. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology, 2007, 148(1), 21-26.
93. Kobelt, P.; Wisser, A.S.; Stengel, A.; Goebel, M.; Bannert, N.; Gourcerol, G.; Inhoff, T.; Noetzel, S.; Wiedenmann, B.; Klapp, B.F.; Taché, Y.; Mönnikes, H. Peripheral obestatin has no effect on feeding behavior and brain Fos expression in rodents. Peptides, 2008, 29(6), 1018-1027.
94. Depoortere, I.; Thijs, T.; Moechars, D.; De Smet, B.; Ver Donck, L.; Peeters, T.L. Effect of peripheral obestatin on food intake and gastric emptying in ghrelin-knockout mice. Br. J. Pharmacol., 2008, 153(7), 1550-1557.
95. Annemie, V.D.; Debby, V.D.; Valentijn, V.; Bart de, S.; Walter, L.; Liliane, S.; Peter Paul de, D. Central administration of obestatin fails to show inhibitory effects on food and water intake in mice. Regul. Pept., 2009, 156(1-3), 77-82.
96. Brunetti, L.; Leone, S.; Orlando, G.; Recinella, L.; Ferrante, C.; Chiavaroli, A.; Di Nisio, C.; Di Michele, P.; Vacca, M. Effects of obestatin on feeding and body weight after standard or cafeteria diet in the rat. Peptides, 2009, 30(7), 1323-1327.
97. Unniappan, S.; Speck, M.; Kieffer, T.J. Metabolic effects of chronic obestatin infusion in rats. Peptides, 2008, 29(8), 1354-1361.
98. Lagaud, G.J., Young, A., Acena, A., Morton, M.F., Barrett, T.D., Shankley, N.P. Retracted notice to: "Obestatin reduces food intake and suppresses body 4 weight gain in rodents [Biochem. Biophys. Res. Commun. 357(1) (2007) 5 264-269]. Biochem. Biophys. Res. Commun., 2009, 388(3), 619.
99. Bresciani, E.; Rapetti, D.; Dona, F.; Bulgarelli, I.; Tamiazzo, L.; Locatelli, V.; Torsello, A. Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. J. Endocrinol. Invest., 2006, 29(8), RC16-RC18.
100. Carlini, V.P.; Schioth, H.B.; Debarioglio, S.R. Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem. Biophys. Res. Commun., 2007, 352(4), 907-912.
101. Nagaraj, S.; Peddha, M.S.; Manjappara, U.V. Fragments of obestatin as modulators of feed intake, circulating lipids, and stored fat. Biochem. Biophys. Res. Commun., 2008, 366(3), 731-737.
102. Germain, N.; Galusca, B.; Grouselle, D.; Frere, D.; Tolle, V.; Zizzari, P.; Lang, F.; Epelbaum, J.; Estour, B. Ghrelin/obestatin ratio in two populations with low bodyweight: constitutional thinness and anorexia nervosa. Psychoneuroendocrinology, 2009, 34(3), 413-419.
103. Germain, N.; Galusca, B.; Grouselle, D.; Frere, D.; Billard, S.; Epelbaum, J.; Estour, B. Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa. J. Clin. Endocrinol. Metab., 2010, 95(6), 3057-3062.
104. Hassouna, R.; Zizzari, P.; Tolle, V. The ghrelin/obestatin balance in the physiological and pathological control of growth hormone secretion, body composition and food intake. J. Neuroendocrinol., 2010, 22(7), 793-804.
105. Oh-I, S.; Shimizu, H.; Satoh, T.; Okada, S.; Adachi, S.; Inoue, K.; Eguchi, H.; Yamamoto, M.; Imaki, T.; Hashimoto, K.; Tsuchiya, T.; Monden, T.; Horiguchi, K.; Yamada, M.; Mori, M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature, 2006, 443(7112), 709-712.
106. Stengel, A.; Goebel, M.; Wang, L.; Rivier, J.; Kobelt, P.; Mönnikes, H.; Lambrecht, N.W.; Taché, Y. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology, 2009, 150(11), 4911-4919.
107. Maejima, Y.; Sedbazar, U.; Suyama, S.; Kohno, D.; Onaka, T.; Takano, E.; Yoshida, N.; Koike, M.; Uchiyama, Y.; Fujiwara, K.; Yashiro, T.; Horvath, T.L.; Dietrich, M.O.; Tanaka, S.; Dezaki, K.; Oh, I.S.; Hashimoto, K.; Shimizu, H.; Nakata, M.; Mori, M.; Yada, T. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab., 2009, 10(5), 355-365.
108. Tsuchiya, T.; Shimizu, H.; Yamada, M.; Osaki, A.; Oh, I.S.; Ariyama, Y.; Takahashi, H.; Okada, S.; Hashimoto, K.; Satoh, T.; Kojima, M.; Mori, M. Fasting Concentrations of Nesfatin-1 Are Negatively Correlated with Body Mass Index in Non-Obese Males. Clin. Endocrinol. (Oxf), 2010, 73(4), 484-90.
109. Gonzalez, R.; Tiwari, A.; Unniappan, S. Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents. Biochem. Biophys. Res. Commun., 2009, 381(4), 643-648.
110. Foo, K.S.; Brauner, H.; Ostenson, C.G.; Broberger, C. Nucleobindin- 2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. J. Endocrinol., 2010, 204(3), 255-263.
111. Shimizu, H., Oh-I, S., Hashimoto, K., Nakata, M., Yamamoto, S., Yoshida, N., Eguchi, H., Kato, I., Inoue, K., Satoh, T., Okada, S., Yamada, M., Yada, T., Mori, M. Peripheral Administration of Nesfatin-1 Reduces Food Intake in Mice: The leptin-independent mechanism. Endocrinology, 2009, 150(2), 662-671.
112. Shimizu, H.; Ohsaki, A.; Oh, I.S.; Okada, S.; Mori, M. A new anorexigenic protein, nesfatin-1. Peptides, 2009, 30(5), 995-998.
113. Beinfeld, M.C.; Korchak, D.M. The regional distribution and the chemical, chromatographic, and immunologic characterization of motilin brain peptides: the evidence for a difference between brain and intestinal motilin-immunoreactive peptides. J. Neurosci., 1985, 5(9), 2502-2509.
114. Liddle, R.A.; Goldfine, I.D.; Rosen, M.S.; Taplitz, R.A.; Williams, J.A. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J. Clin. Invest., 1985, 75(4), 1144-1152.
115. Herness, S.; Zhao, F.L.; Lu, S.G.; Kaya, N.; Shen, T. Expression and physiological actions of cholecystokinin in rat taste receptor cells. J. Neurosci., 2002, 22(22), 10018-10029.
116. Shen, T.; Kaya, N.; Zhao, F.L.; Lu, S.G.; Cao, Y.; Herness, S. Coexpression patterns of the neuropeptides vasoactive intestinal peptide and cholecystokinin with the transduction molecules alphagustducin and T1R2 in rat taste receptor cells. Neuroscience, 2005, 130(1), 229-238.
117. Hajnal, A.; Covasa, M.; Bello, N.T. Altered taste sensitivity in obese, prediabetic OLETF rats lacking CCK-1 receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2005, 289(6), R1675-R1686.
118. Swartz, T.D.; Hajnal, A.; Covasa, M. Altered orosensory sensitivity to oils in CCK-1 receptor deficient rats. Physiol. Behav., 2010, 99(1), 109-117.
119. Hao, S.; Sternini, C.; Raybould, H.E. Role of CCK1 and Y2 receptors in activation of hindbrain neurons induced by intragastric administration of bitter taste receptor ligands. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2008, 294(1), R33-R38.
120. Linden, A.; Carlquist, M.; Hansen, S.; Uvnas-Moberg, K. Plasma concentrations of cholecystokinin, CCK-8, and CCK-33, 39 in rats, determined by a method based on enzyme digestion of gastrin before HPLC and RIA detection of CCK. Gut, 1989, 30(2), 213-222.
121. Folsch, U.R.; Cantor, P.; Wilms, H.M.; Schafmayer, A.; Becker, H.D.; Creutzfeldt, W. Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. Gastroenterology, 1987, 92(2), 449-458.
122. Liddle, R.A.; Goldfine, I.D.; Williams, J.A. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology, 1984, 87(3), 542-549.
123. Izzo, R.S.; Brugge, W.R.; Praissman, M. Immunoreactive cholecystokinin in human and rat plasma: correlation of pancreatic secretion in response to CCK. Regul. Pept., 1984, 9(1-2), 21-34.
124. Reeve, J.R., Jr.; Green, G.M.; Chew, P.; Eysselein, V.E.; Keire, D.A. CCK-58 is the only detectable endocrine form of cholecystokinin in rat. Am. J. Physiol. Gastrointest. Liver Physiol., 2003, 285(2), G255-G265.
125. Reeve, J.R., Jr.; Wu, S.V.; Keire, D.A.; Faull, K.; Chew, P.; Solomon, T.E.; Green, G.M.; Coskun, T. Differential bile-pancreatic secretory effects of CCK-58 and CCK-8. Am. J. Physiol. Gastrointest. Liver Physiol., 2004, 286(3), G395-G402.
126. Cooper, M.S.; Reeve, J.R., Jr.; Raboin, S.J.; Abdalla, M.O.; Green, G.M.; Sayegh, A.I. Cholecystokinin-58 and cholecystokinin-8 produce similar but not identical activations of myenteric plexus and dorsal vagal complex. Regul. Pept., 2008, 148(1-3), 88-94.
127. Kreis, M.E.; Zittel, T.T.; Raybould, H.E.; Reeve, J.R., Jr.; Grundy, D. Prolonged intestinal afferent nerve discharge in response to cholecystokinin-58 compared to cholecystokinin-8 in rats. Neurosci. Lett., 1997, 230(2), 89-92.
128. Glatzle, J.; Raybould, H.E.; Kueper, M.A.; Reeve, J.R., Jr.; Zittel, T.T. Cholecystokinin-58 is more potent in inhibiting food intake than cholecystokinin-8 in rats. Nutr. Neurosci., 2008, 11(2), 69-74.
129. Yamamoto, M.; Reeve, J.R., Jr.; Keire, D.A.; Green, G.M. Water and enzyme secretion are tightly coupled in pancreatic secretion stimulated by food or CCK-58 but not by CCK-8. Am. J. Physiol. Gastrointest. Liver Physiol., 2005, 288(5), G866-G879.
130. Criddle, D.N.; Booth, D.M.; Mukherjee, R.; McLaughlin, E.; Green, G.M.; Sutton, R.; Petersen, O.H.; Reeve, J.R.,Jr. Cholecystokinin-58 and cholecystokinin-8 exhibit similar actions on calcium signaling, zymogen secretion, and cell fate in murine pancreatic acinar cells. Am. J. Physiol. Gastrointest. Liver Physiol., 2009, 297(6), G1085-G1092.
131. Liddle, R.A.; Elashoff, J.; Reeve, J.R., Jr. Relative bioactivities of cholecystokinins-8 and -33 on rat pancreatic acini. Peptides, 1986, 7(5), 723-727.
132. van der Schaar, P.J.; Bremer, Y.; Lamers, C.B.; Masclee, A.A. Role of cholecystokinin in relaxation of the proximal stomach. Scand. J. Gastroenterol., 2001, 36(4), 361-366.
133. Gibbs, J.; Young, R.C.; Smith, G.P. Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature, 1973, 245(5424), 323-325.
134. Stacher, G.; Steinringer, H.; Schmierer, G.; Schneider, C.; Winklehner, S. Cholecystokinin octapeptide decreases intake of solid food in man. Peptides, 1982, 3(2), 133-136.
135. Reidelberger, R.D.; Arnelo, U.; Granqvist, L.; Permert, J. Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2001, 280(3), R605-R611.
136. Asin, K.E.; Gore, P.A., Jr.; Bednarz, L.; Holladay, M.; Nadzan, A.M. Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats. Brain Res., 1992, 571(1), 169-174.
137. Kraly, F.S.; Carty, W.J.; Resnick, S.; Smith, G.P. Effect of cholecystokinin on meal size and intermeal interval in the sham-feeding rat. J. Comp. Physiol. Psychol., 1978, 92(4), 697-707.
138. Stark, H.A.; Sharp, C.M.; Sutliff, V.E.; Martinez, J.; Jensen, R.T.; Gardner, J.D. CCK-JMV-180: a peptide that distinguishes highaffinity cholecystokinin receptors from low-affinity cholecystokinin receptors. Biochim. Biophys. Acta, 1989, 1010(2), 145-150.
139. Weatherford, S.C.; Laughton, W.B.; Salabarria, J.; Danho, W.; Tilley, J.W.; Netterville, L.A.; Schwartz, G.J.; Moran, T.H. CCK satiety is differentially mediated by high- and low-affinity CCK receptors in mice and rats. Am. J. Physiol., 1993, 264(2 Pt 2), R244-R249.
140. Sakurai, C.; Ohta, M.; Kanai, S.; Uematsu, H.; Funakoshi, A.; Miyasaka, K. Lack of ghrelin secretion in response to fasting in cholecystokinin-A (-1), -B (-2) receptor-deficient mice. J. Physiol. Sci., 2006, 56(6), 441-417.
141. Donovan, M.J.; Paulino, G.; Raybould, H.E. CCK(1) receptor is essential for normal meal patterning in mice fed high fat diet. Physiol. Behav., 2007, 92(5), 969-9674.
142. Lo, C.M.; King, A.; Samuelson, L.C.; Kindel, T.L.; Rider, T.; Jandacek, R.J.; Raybould, H.E.; Woods, S.C.; Tso, P. Cholecystokinin knockout mice are resistant to high-fat diet-induced obesity. Gastroenterology, 2010, 138(5), 1997-2005.
143. Clerc, P.; Coll Constans, M.G.; Lulka, H.; Broussaud, S.; Guigne, C.; Leung-Theung-Long, S.; Perrin, C.; Knauf, C.; Carpene, C.; Penicaud, L.; Seva, C.; Burcelin, R.; Valet, P.; Fourmy, D.; Dufresne, M. Involvement of cholecystokinin 2 receptor in food intake regulation: hyperphagia and increased fat deposition in cholecystokinin 2 receptor-deficient mice. Endocrinology, 2007, 148(3), 1039-1049.
144. Blackshaw, L.A.; Grundy, D. Effects of cholecystokinin (CCK-8) on two classes of gastroduodenal vagal afferent fibre. J. Auton. Nerv. Syst., 1990, 31(3), 191-201.
145. Smith, G.P.; Jerome, C.; Cushin, B.J.; Eterno, R.; Simansky, K.J. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science, 1981, 213(4511), 1036-1037.
146. Beglinger, C.; Degen, L.; Matzinger, D.; D'Amato, M.; Drewe, J. Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2001, 280(4), R1149-R1154.
147. Kobelt, P.; Tebbe, J.J.; Tjandra, I.; Stengel, A.; Bae, H.G.; Andresen, V.; van der Voort, I.R.; Veh, R.W.; Werner, C.R.; Klapp, B.F.; Wiedenmann, B.; Wang, L.; Taché, Y.; Mönnikes, H. CCK inhibits the orexigenic effect of peripheral ghrelin. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2005, 288(3), R751-R758.
148. Noetzel, S.; Stengel, A.; Inhoff, T.; Goebel, M.; Wisser, A.S.; Bannert, N.; Wiedenmann, B.; Klapp, B.F.; Taché, Y.; Mönnikes, H.; Kobelt, P. CCK-8S activates c-Fos in a dose-dependent manner in nesfatin-1 immunoreactive neurons in the paraventricular nucleus of the hypothalamus and in the nucleus of the solitary tract of the brainstem. Regul. Pept., 2009, 157(1-3), 84-91.
149. Peter, L., Stengel, A., Noetzel, S., Inhoff, T., Goebel, M., Taché, Y., Veh, R.W., Bannert, N., Grötzinger, C., Wiedenmann, B., Klapp, B.F., Mönnikes, H., Kobelt, P. Peripherally injected CCK-8S activates CART positive Neurons of the Paraventricular Nucleus in Rats. Peptides, 2010, 31(6), 1118-1123.
150. Date, Y.; Toshinai, K.; Koda, S.; Miyazato, M.; Shimbara, T.; Tsuruta, T.; Niijima, A.; Kangawa, K.; Nakazato, M. Peripheral interaction of ghrelin with cholecystokinin on feeding regulation. Endocrinology, 2005, 146(8), 3518-3525.
151. Brennan, I.M.; Otto, B.; Feltrin, K.L.; Meyer, J.H.; Horowitz, M.; Feinle-Bisset, C. Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy men. Peptides, 2007, 28(3), 607-611.
152. Eissele, R.; Koop, I.; Schaar, M.; Koop, H.; Arnold, R. Role of cholecystokinin in the control of gastric somatostatin in the rat: in vivo and in vitro studies. Regul. Pept., 1991, 32(3), 333-340.
153. Saad, M.F.; Bernaba, B.; Hwu, C.M.; Jinagouda, S.; Fahmi, S.; Kogosov, E.; Boyadjian, R. Insulin regulates plasma ghrelin concentration. J. Clin. Endocrinol. Metab., 2002, 87(8), 3997-4000.
154. Shimada, M.; Date, Y.; Mondal, M.S.; Toshinai, K.; Shimbara, T.; Fukunaga, K.; Murakami, N.; Miyazato, M.; Kangawa, K.; Yoshimatsu, H.; Matsuo, H.; Nakazato, M. Somatostatin suppresses ghrelin secretion from the rat stomach. Biochem. Biophys. Res. Commun., 2003, 302(3), 520-525.
155. de la Cour, C.D.; Norlen, P.; Hakanson, R. Secretion of ghrelin from rat stomach ghrelin cells in response to local microinfusion of candidate messenger compounds: a microdialysis study. Regul. Pept., 2007, 143(1-3), 118-126.
156. Hagemann, D.; Holst, J.J.; Gethmann, A.; Banasch, M.; Schmidt, W.E.; Meier, J.J. Glucagon-like peptide 1 (GLP-1) suppresses ghrelin levels in humans via increased insulin secretion. Regul. Pept., 2007, 143(1-3), 64-68.
157. Lippl, F.; Kircher, F.; Erdmann, J.; Allescher, H.D.; Schusdziarra, V. Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach. Regul. Pept., 2004, 119(1-2), 93-98.
158. Perez-Tilve, D.; Gonzalez-Matias, L.; Alvarez-Crespo, M.; Leiras, R.; Tovar, S.; Dieguez, C.; Mallo, F. Exendin-4 potently decreases ghrelin levels in fasting rats. Diabetes, 2007, 56(1), 143-151.
159. Zbucki, R.L.; Sawicki, B.; Hryniewicz, A.; Winnicka, M.M. Cannabinoids enhance gastric X/A-like cells activity. Folia Histochem. Cytobiol., 2008, 46(2), 219-224.
160. Barrachina, M.D.; Martinez, V.; Wang, L.; Wei, J.Y.; Taché, Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc. Natl. Acad. Sci. USA, 1997, 94(19), 10455-10460.
161. Gourcerol, G.; Wang, L.; Wang, Y.H.; Million, M.; Taché, Y. Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropinreleasing factor receptor-2 pathway. Endocrinology, 2007, 148(12), 6115-6123.
162. Gutzwiller, J.P.; Degen, L.; Matzinger, D.; Prestin, S.; Beglinger, C. Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2004, 287(3), R562-R527.
163. Bhavsar, S.; Watkins, J.; Young, A. Synergy between amylin and cholecystokinin for inhibition of food intake in mice. Physiol. Behav., 1998, 64(4), 557-561.
164. Peters, J.H.; Ritter, R.C.; Simasko, S.M. Leptin and CCK selectively activate vagal afferent neurons innervating the stomach and duodenum. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2006, 290(6), R1544-R1549.
165. Wang, Y.H.; Taché, Y.; Sheibel, A.B.; Go, V.L.; Wei, J.Y. Two types of leptin-responsive gastric vagal afferent terminals: an in vitro single-unit study in rats. Am. J. Physiol., 1997, 273(2 Pt 2), R833-R837.
166. de Lartigue, G.; Dimaline, R.; Varro, A.; Dockray, G.J. Cocaineand amphetamine-regulated transcript: stimulation of expression in rat vagal afferent neurons by cholecystokinin and suppression by ghrelin. J. Neurosci., 2007, 27(11), 2876-2882.
167. Burdyga, G.; Varro, A.; Dimaline, R.; Thompson, D.G.; Dockray, G.J. Feeding-dependent depression of melanin-concentrating hormone and melanin-concentrating hormone receptor-1 expression in vagal afferent neurones. Neuroscience, 2006, 137(4), 1405-1415.
168. Burdyga, G.; Lal, S.; Varro, A.; Dimaline, R.; Thompson, D.G.; Dockray, G.J. Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. J. Neurosci., 2004, 24(11), 2708-2715.
169. Burdyga, G.; de Lartigue, G.; Raybould, H.E.; Morris, R.; Dimaline, R.; Varro, A.; Thompson, D.G.; Dockray, G.J. Cholecystokinin regulates expression of Y2 receptors in vagal afferent neurons serving the stomach. J. Neurosci., 2008, 28(45), 11583-11592.
170. Kobelt, P.; Paulitsch, S.; Goebel, M.; Stengel, A.; Schmidtmann, M.; van der Voort, I.R.; Tebbe, J.J.; Veh, R.W.; Klapp, B.F.; Wiedenmann, B.; Taché, Y.; Mönnikes, H. Peripheral injection of CCK-8S induces Fos expression in the dorsomedial hypothalamic nucleus in rats. Brain Res., 2006, 1117(1), 109-117.
171. Price, C.J.; Samson, W.K.; Ferguson, A.V. Nesfatin-1 inhibits NPY neurons in the arcuate nucleus. Brain Res., 2008, 1230, 99-106.